|
1
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 16:589–604. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanwal F and Singal AG: Surveillance for
hepatocellular carcinoma: Current best practice and future
direction. Gastroenterology. 157:54–64. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji S, Liu Q, Zhang S, Chen Q, Wang C,
Zhang W, Xiao C, Li Y, Nian C, Li J, et al: FGF15 activates Hippo
signaling to suppress bile acid metabolism and liver tumorigenesis.
Dev Cell. 48:460–474.e9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dent P, Booth L, Roberts JL, Liu J,
Poklepovic A, Lalani AS, Tuveson D, Martinez J and Hancock JF:
Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS
expression, and kills pancreatic and blood cancer cells. Oncogene.
38:5890–5904. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang Z, Zhou JK, Wang K, Chen H, Qin S,
Liu J, Luo M, Chen Y, Jiang J, Zhou L, et al: PDLIM1 inhibits tumor
metastasis through activating Hippo signaling in hepatocellular
carcinoma. Hepatology. 71:1643–1659. 2020. View Article : Google Scholar
|
|
7
|
Meng Z, Moroishi T and Guan KL: Mechanisms
of Hippo pathway regulation. Genes Dev. 30:1–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou D, Conrad C, Xia F, Park JS, Payer B,
Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, et al: Mst1 and
Mst2 maintain hepatocyte quiescence and suppress hepatocellular
carcinoma development through inactivation of the Yap1 oncogene.
Cancer Cell. 16:425–438. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng X, Lu T, Li J, Yang R, Hu L, Ye Y,
Mao F, He L, Xu J, Wang Z, et al: The tumor suppressor interferon
regulatory factor 2 binding protein 2 regulates Hippo pathway in
liver cancer by a feedback loop in mice. Hepatology. 71:1988–2004.
2020. View Article : Google Scholar
|
|
10
|
Li Y, Lu J, Chen Q, Han S, Shao H, Chen P,
Jin Q, Yang M, Shangguan F, Fei M, et al: Artemisinin suppresses
hepatocellular carcinoma cell growth, migration and invasion by
targeting cellular bioenergetics and Hippo-YAP signaling. Arch
Toxicol. 93:3367–3383. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun S and Irvine KD: Cellular organization
and cytoskeletal regulation of the Hippo signaling network. Trends
Cell Biol. 26:694–704. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Q, Zhou XW, Zhang AJ and He K: ACTN1
supports tumor growth by inhibiting Hippo signaling in
hepatocellular carcinoma. J Exp Clin Cancer Res. 40:232021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang XM, Cao XY, He P, Li J, Feng MX,
Zhang YL, Zhang XL, Wang YH, Yang Q, Zhu L, et al: Overexpression
of Rac GTPase activating protein 1 contributes to proliferation of
cancer cells by reducing Hippo signaling to promote cytokinesis.
Gastroenterology. 155:1233–1249.e22. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Longtine MS, DeMarini DJ, Valencik ML,
Al-Awar OS, Fares H, De Virgilio C and Pringle JR: The septins:
Roles in cytokinesis and other processes. Curr Opin Cell Biol.
8:106–119. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mostowy S and Cossart P: Septins: The
fourth component of the cytoskeleton. Nat Rev Mol Cell Biol.
13:183–194. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu J, Bai X, Bowen JR, Dolat L, Korobova
F, Yu W, Baas PW, Svitkina T, Gallo G and Spiliotis ET:
Septin-driven coordination of actin and microtubule remodeling
regulates the collateral branching of axons. Curr Biol.
22:1109–1115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kremer BE, Adang LA and Macara IG: Septins
regulate actin organization and cell-cycle arrest through nuclear
accumulation of NCK mediated by SOCS7. Cell. 130:837–850. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei Y, Yang J, Yi L, Wang Y, Dong Z, Liu
Z, Ou-yang S, Wu H, Zhong Z, Yin Z, et al: MiR-223-3p targeting
SEPT6 promotes the biological behavior of prostate cancer. Sci Rep.
4:75462014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fan Y, Du Z, Steib CJ, Ding Q, Lu P, Tian
D and Liu M: Effect of SEPT6 on the biological behavior of hepatic
stellate cells and liver fibrosis in rats and its mechanism. Lab
Invest. 99:17–36. 2019. View Article : Google Scholar
|
|
20
|
Xiangji L, Feng X, Qingbao C, Weifeng T,
Xiaoqing J, Baihe Z, Feng S, Hongyang W and Mengchao W: Knockdown
of HBV surface antigen gene expression by a lentiviral
microRNA-based system inhibits HBV replication and HCC growth. J
Viral Hepat. 18:653–660. 2011. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Kondo R, Ishino K, Wada R, Takata H, Peng
WX, Kudo M, Kure S, Kaneya Y, Taniai N, Yoshida H, et al:
Downregulation of protein disulfide isomerase A3 expression
inhibits cell proliferation and induces apoptosis through STAT3
signaling in hepatocellular carcinoma. Int J Oncol. 54:1409–1421.
2019.PubMed/NCBI
|
|
23
|
Li Y, Tang ZY and Hou JX: Hepatocellular
carcinoma: Insight from animal models. Nat Rev Gastroenterol
Hepatol. 9:32–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun F, Wang J, Sun Q, Li F, Gao H, Xu L,
Zhang J, Sun X, Tian Y, Zhao Q, et al: Interleukin-8 promotes
integrin β3 upregulation and cell invasion through PI3K/Akt pathway
in hepatocellular carcinoma. J Exp Clin Cancer Res. 38:4492019.
View Article : Google Scholar
|
|
25
|
Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW,
Qiu SJ, Wang XY, Dai Z, Xu Y and Fan J: Liver-intestine cadherin
predicts microvascular invasion and poor prognosis of hepatitis B
virus-positive hepatocellular carcinoma. Cancer. 115:4753–4765.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia H, Dai X, Yu H, Zhou S, Fan Z, Wei G,
Tang Q, Gong Q and Bi F: EGFR-PI3K-PDK1 pathway regulates YAP
signaling in hepatocellular carcinoma: The mechanism and its
implications in targeted therapy. Cell Death Dis. 9:2692018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cerveira N, Bizarro S and Teixeira MR:
MLL-SEPTIN gene fusions in hematological malignancies. Biol Chem.
392:713–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Y, Tong JH, Lung RW, Kang W, Kwan JS,
Chak WP, Tin KY, Chung LY, Wu F, Ng SS, et al: RASAL2 promotes
tumor progression through LATS2/YAP1 axis of hippo signaling
pathway in colorectal cancer. Mol Cancer. 17:1022018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Xu ZP, Yang YC, Zhu JS, Zhou Z
and Chen WX: Expression of Yes-associated protein in gastric
adenocarcinoma and inhibitory effects of its knockdown on gastric
cancer cell proliferation and metastasis. Int J Immunopathol
Pharmacol. 25:583–590. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie K, Xu C, Zhang M, Wang M, Min L, Qian
C, Wang Q, Ni Z, Mou S, Dai H, et al: Yes-associated protein
regulates podocyte cell cycle re-entry and dedifferentiation in
adriamycin-induced nephropathy. Cell Death Dis. 10:9152019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang C, Wang F, Gao Z, Zhang P, Gao J and
Wu X: Regulation of Hippo signaling by mechanical signals and the
cytoskeleton. DNA Cell Biol. 39:159–166. 2020. View Article : Google Scholar
|
|
32
|
Matsui Y and Lai ZC: Mutual regulation
between Hippo signaling and actin cytoskeleton. Protein Cell.
4:904–910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xue Y, Bhushan B, Mars WM, Bowen W, Tao J,
Orr A, Stoops J, Yu Y, Luo J, Duncan AW, et al: Phosphorylated
Ezrin (Thr567) regulates Hippo pathway and yes-associated protein
(Yap) in liver. Am J Pathol. 190:1427–1437. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsuda T, Zhai P, Sciarretta S, Zhang Y,
Jeong JI, Ikeda S, Park J, Hsu CP, Tian B, Pan D, et al: NF2
activates Hippo signaling and promotes ischemia/reperfusion injury
in the heart. Circ Res. 119:596–606. 2016. View Article : Google Scholar : PubMed/NCBI
|
